Inability of OKT3 to prevent donor-derived ABO hemolytic anemia in a kidney-pancreas transplant recipient.
Doutrelepont
J M
JM
Abramowicz
D
D
Lambermont
M
M
Kinnaert
P
P
Vanherweghem
J L
JL
Vereerstraeten
P
P
Goldman
M
M
De Pauw
L
L
D000328:Adult; D000743:Anemia, Hemolytic / Q000209:etiology* / Q000517:prevention & control; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D016853:Muromonab-CD3 / Q000008:administration & dosage*; D016035:Pancreas Transplantation / Q000009:adverse effects*
D016853:Muromonab-CD3